视网膜母细胞瘤动脉内化疗的新进展有哪些？ - Suppr

Suppr

超能文献

What's New in Intra-Arterial Chemotherapy for Retinoblastoma?

作者信息

Abramson David H, Francis Jasmine H, Gobin Yves Pierre

出版信息

Int Ophthalmol Clin. 2019 Spring;59(2):87-94. doi: 10.1097/IIO.0000000000000266.

DOI:10.1097/IIO.0000000000000266

PMID:30908282

Abstract

摘要

相似文献

What's New in Intra-Arterial Chemotherapy for Retinoblastoma?视网膜母细胞瘤动脉内化疗的新进展有哪些？

Int Ophthalmol Clin. 2019 Spring;59(2):87-94. doi: 10.1097/IIO.0000000000000266.

Intra-arterial chemotherapy in retinoblastoma - A paradigm change.眼内动脉化疗治疗视网膜母细胞瘤——一种范式转变。

Indian J Ophthalmol. 2019 Jun;67(6):740-754. doi: 10.4103/ijo.IJO_866_19.

Chemosurgery for retinoblastoma: what we know after 5 years.视网膜母细胞瘤的化学外科治疗：5年后我们所了解的情况。

Arch Ophthalmol. 2011 Nov;129(11):1492-4. doi: 10.1001/archophthalmol.2011.354.

Retinoblastoma therapy delivers power of chemotherapy with surgical precision.视网膜母细胞瘤治疗将化疗的力量与手术的精准性相结合。

JAMA. 2011 Jun 8;305(22):2276-8. doi: 10.1001/jama.2011.778.

Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications.瑞典视网膜母细胞瘤的动脉内化疗——治疗效果及并发症评估

Acta Ophthalmol. 2018 Dec;96(8):e1040-e1041. doi: 10.1111/aos.13796. Epub 2018 Apr 24.

Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture.超选择性眼动脉化疗治疗眼内视网膜母细胞瘤：“化学手术”——首届斯塔拉德讲座

Br J Ophthalmol. 2010 Apr;94(4):396-9. doi: 10.1136/bjo.2009.174268.

[The key points in intravenous chemotherapy and intra-arterial chemotherapy on retinoblastoma treatment].[视网膜母细胞瘤治疗中静脉化疗和动脉化疗的关键点]

Zhonghua Yan Ke Za Zhi. 2017 Aug 11;53(8):566-569. doi: 10.3760/cma.j.issn.0412-4081.2017.08.002.

Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.视网膜母细胞瘤静脉化疗与动脉化疗的不良事件、治疗负担及结果

Ophthalmol Retina. 2021 Mar;5(3):309-312. doi: 10.1016/j.oret.2020.09.006. Epub 2020 Sep 11.

Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.动脉内化疗治疗视网膜母细胞瘤：四年经验

Arch Ophthalmol. 2011 Jun;129(6):732-7. doi: 10.1001/archophthalmol.2011.5. Epub 2011 Feb 14.

Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.眼内动脉化疗治疗伴有玻璃体内和/或视网膜下种植的视网膜母细胞瘤：2 年结果。

Br J Ophthalmol. 2012 Apr;96(4):499-502. doi: 10.1136/bjophthalmol-2011-300498. Epub 2011 Nov 3.

引用本文的文献

Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 Months Old or under 6-kg Weight.用于3个月以下或体重6公斤以下视网膜母细胞瘤婴儿的眼动脉化学手术

Ophthalmol Retina. 2025 Mar 20. doi: 10.1016/j.oret.2025.03.008.

J Pediatr Hematol Oncol Nurs. 2022 Nov-Dec;39(6):342-357. doi: 10.1177/27527530221073766. Epub 2022 Jun 8.

Optimizing CARs for ocular delivery.优化用于眼部递送的 CARs。

Nat Cancer. 2020 Oct;1(10):939-940. doi: 10.1038/s43018-020-00127-y. Epub 2020 Oct 12.

Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery).眼动脉化疗（动脉化学疗法）成功治疗视网膜母细胞瘤的巨大脉络膜侵犯。

Ophthalmol Retina. 2021 Sep;5(9):936-939. doi: 10.1016/j.oret.2020.12.018. Epub 2020 Dec 29.

Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.13q 缺失综合征患者采用超选择性化疗和其他癌症靶向干预治疗视网膜母细胞瘤。

Pediatr Blood Cancer. 2021 May;68(5):e28845. doi: 10.1002/pbc.28845. Epub 2020 Dec 23.

A decision process for drug discovery in retinoblastoma.视网膜母细胞瘤药物发现的决策过程。

Invest New Drugs. 2021 Apr;39(2):426-441. doi: 10.1007/s10637-020-01030-0. Epub 2020 Nov 16.

Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.MSKCC 经验：晚期眼内疾病的视网膜母细胞瘤患者的游离 DNA 分析。

Cancer Med. 2020 Sep;9(17):6093-6101. doi: 10.1002/cam4.3144. Epub 2020 Jul 7.

Intra-arterial chemotherapy in retinoblastoma - A paradigm change.眼内动脉化疗治疗视网膜母细胞瘤——一种范式转变。

Indian J Ophthalmol. 2019 Jun;67(6):740-754. doi: 10.4103/ijo.IJO_866_19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验